The Office of the United States Trade Representative (USTR), faced with the current COVID-19 pandemic, has moved quickly to grant numerous exclusion requests in March 2020; many of which are for medical supplies. USTR is also seeking comments from industry on whether products are necessary to combat COVID-19 spread and should be excluded from the additional duties. DTL has assisted clients in submitting comments to the USTR – this is the time to let your voice be heard.
Below is a chart summarizing recent changes to Section 301 Tariffs:
Showing posts with label Comments. Show all posts
Showing posts with label Comments. Show all posts
Saturday, March 28, 2020
Friday, August 3, 2018
Deadline Approaching - Why Should Your Product Not Be on The 301 List!
We have been working hard to keep you up to date on the current Trade War between the United States and China.China has taken retaliatory actions against the United States in response to the first wave of additional U.S. duties that became effective on July 6, 2018. The United States is gearing up to impose a second round of 10% additional duties on approximately $200 billion worth of products of Chinese origin. The USTR has also been directed to consider levying a 25% tariff on these $200 billion worth of Chinese imports - thereby increasing the 10% to 25%.
Now, you have the ability to tell USTR why your products should not be on the 301 List.
Subscribe to:
Posts (Atom)
